Rachel Anne Allbaugh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rachel Anne Allbaugh has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Lionel Sebbag
Koret School of Veterinary Medicine The Hebrew University of Jerusalem Rehovot Israel
15 shared publications Gil Ben‐Shlomo
Department of Veterinary Clinical Sciences, Iowa State University College of Veterinary Medicine, 1600 S. 16th St, Ames, IA, 50011, USA
7 shared publicationsAmy J. Rankin
6 shared publications- Jonathan Paul Mochel
University of Georgia
6 shared publications Kyle L. Tofflemire
Department of Veterinary Clinical Sciences, Lloyd Veterinary Medical Center, College of Veterinary Medicine, Iowa State University, Ames, IA, 50011
6 shared publicationsElizabeth M. Whitley
5 shared publications
Latest Publications
- Open Access
- 2 August 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (5) , e70238
Sustained Tear Film Exposure After Parenteral Cefovecin Administration in Dogs: Pharmacokinetics and Relevance to Canine Bacterial Keratitis
Objective: To characterize the tear film pharmacokinetics of parenterally administered cefovecin (Convenia) and compare tear concentrations with the minimum inhibitory concentrations (MICs) of common ocular pathogens. Animals Studied: Six healthy research‐bred Beagles. Procedures: Dogs received a single subcutaneous injection of cefovecin (8 mg/kg) after inducing blood‐tear barrier disruption through histamine‐mediated conjunctivitis. Tear fluid was collected using Schirmer strips at multiple time points up to 336 h and analyzed via liquid chromatography–mass spectrometry. Tear concentrations from both eyes were averaged for analysis. MIC values were determined for Staphylococcus pseudintermedius , Streptococcus canis , and Pseudomonas aeruginosa ( n = 10 isolates per species). Results: In a pilot experiment ( n = 1 dog), tear cefovecin concentrations were 1.5 to 430‐fold higher in the conjunctivitis eye than in the control eye at all but one time point. Across all dogs, tear concentrations ranged from 68 to 73 035 ng/mL and remained detectable throughout the 336‐h study. Mean ± SD pharmacokinetic parameters were: C max 27.23 ± 27.74 μg/mL, T max 61 ± 83 h, AUC 2734 ± 2563 μg/mL·h, and t 1/2 64 ± 46 h. Tear concentrations exceeded the MIC 90 for Streptococcus (0.64 μg/mL) for 336 h and exceeded the MIC 90 for some Staphylococcus (10.2 μg/mL) between 48 and 120 h, but remained below the MIC 90 for Pseudomonas . Conclusions: Parenteral cefovecin achieved sustained tear concentrations sufficient to inhibit some susceptible Streptococcus and Staphylococcus isolates in vitro for clinically relevant time windows. While these findings support further investigation of cefovecin as an adjunctive therapy in selected cases, they do not justify empiric systemic antimicrobial use. Larger pharmacokinetic and clinical studies are warranted to validate these findings.
- 2 August 2026
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (5) , e70238
Open AccessSustained Tear Film Exposure After Parenteral Cefovecin Administration in Dogs: Pharmacokinetics and Relevance to Canine Bacterial Keratitis
Objective: To characterize the tear film pharmacokinetics of parenterally administered cefovecin (Convenia) and compare tear concentrations with the minimum inhibitory concentrations (MICs) of common ocular pathogens. Animals Studied: Six healthy research‐bred Beagles. Procedures: Dogs received a single subcutaneous injection of cefovecin (8 mg/kg) after inducing blood‐tear barrier disruption through histamine‐mediated conjunctivitis. Tear fluid was collected using Schirmer strips at multiple time points up to 336 h and analyzed via liquid chromatography–mass spectrometry. Tear concentrations from both eyes were averaged for analysis. MIC values were determined for Staphylococcus pseudintermedius , Streptococcus canis , and Pseudomonas aeruginosa ( n = 10 isolates per species). Results: In a pilot experiment ( n = 1 dog), tear cefovecin concentrations were 1.5 to 430‐fold higher in the conjunctivitis eye than in the control eye at all but one time point. Across all dogs, tear concentrations ranged from 68 to 73 035 ng/mL and remained detectable throughout the 336‐h study. Mean ± SD pharmacokinetic parameters were: C max 27.23 ± 27.74 μg/mL, T max 61 ± 83 h, AUC 2734 ± 2563 μg/mL·h, and t 1/2 64 ± 46 h. Tear concentrations exceeded the MIC 90 for Streptococcus (0.64 μg/mL) for 336 h and exceeded the MIC 90 for some Staphylococcus (10.2 μg/mL) between 48 and 120 h, but remained below the MIC 90 for Pseudomonas . Conclusions: Parenteral cefovecin achieved sustained tear concentrations sufficient to inhibit some susceptible Streptococcus and Staphylococcus isolates in vitro for clinically relevant time windows. While these findings support further investigation of cefovecin as an adjunctive therapy in selected cases, they do not justify empiric systemic antimicrobial use. Larger pharmacokinetic and clinical studies are warranted to validate these findings.
- Open Access
- 31 July 2026
- Published by Wiley in Veterinary Record
Oral non‐steroidal anti‐inflammatory drugs do not delay corneal healing in dogs with spontaneous chronic corneal epithelial defects: A retrospective cohort of 186 ulcers
Background: Oral non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly used for analgesia in dogs with spontaneous chronic corneal epithelial defects (SCCEDs). Topical NSAIDs can delay epithelialisation and promote stromal melting, but the safety of systemic NSAIDs in SCCEDs is unknown. Methods: Medical records of dogs with SCCEDs (2018–2024) were reviewed. Affected eyes were grouped by systemic therapy at presentation: oral NSAIDs versus no oral NSAIDs. All cases underwent a corneal debridement procedure. The primary outcome was time to corneal re‐epithelialisation; secondary outcomes were number of procedures needed for healing and complications (stromal melting, descemetocoele, perforation). Results: A total of 186 SCCEDs in 170 dogs met inclusion criteria; 136 were treated with an oral NSAID and 50 without. The median ± standard error healing time was 15 ± 1.0 days (range: 6–74) for the NSAID group and 15 ± 1.5 days (range: 6–49) for the no‐NSAID group ( p = 0.638). The median number of procedures required before healing was one (range: 1–3) in both the NSAID and no‐NSAID groups ( p = 0.210). No cases developed stromal melting, descemetocoele or perforation. Limitations: The retrospective, non‐randomised design limits the wider generalisability of the findings. Conclusion: Short‐term oral NSAID therapy did not delay epithelial healing or increase complications, supporting their safe use in dogs with SCCEDs.
- 31 July 2026
- Published by Wiley in Veterinary Record
Open AccessOral non‐steroidal anti‐inflammatory drugs do not delay corneal healing in dogs with spontaneous chronic corneal epithelial defects: A retrospective cohort of 186 ulcers
Background: Oral non‐steroidal anti‐inflammatory drugs (NSAIDs) are commonly used for analgesia in dogs with spontaneous chronic corneal epithelial defects (SCCEDs). Topical NSAIDs can delay epithelialisation and promote stromal melting, but the safety of systemic NSAIDs in SCCEDs is unknown. Methods: Medical records of dogs with SCCEDs (2018–2024) were reviewed. Affected eyes were grouped by systemic therapy at presentation: oral NSAIDs versus no oral NSAIDs. All cases underwent a corneal debridement procedure. The primary outcome was time to corneal re‐epithelialisation; secondary outcomes were number of procedures needed for healing and complications (stromal melting, descemetocoele, perforation). Results: A total of 186 SCCEDs in 170 dogs met inclusion criteria; 136 were treated with an oral NSAID and 50 without. The median ± standard error healing time was 15 ± 1.0 days (range: 6–74) for the NSAID group and 15 ± 1.5 days (range: 6–49) for the no‐NSAID group ( p = 0.638). The median number of procedures required before healing was one (range: 1–3) in both the NSAID and no‐NSAID groups ( p = 0.210). No cases developed stromal melting, descemetocoele or perforation. Limitations: The retrospective, non‐randomised design limits the wider generalisability of the findings. Conclusion: Short‐term oral NSAID therapy did not delay epithelial healing or increase complications, supporting their safe use in dogs with SCCEDs.
- Open Access
- 5 March 2025
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (1)
Ultraviolet C ( UV ‐C) Light Therapy for Equine Ulcerative Keratomycosis—An In Vitro Study
Objectives: To assess if an affordable, commercially available 275 nm ultraviolet C (UV‐C) device can inhibit fungal pathogens associated with equine keratomycosis and to establish the optimal exposure time/dose required in vitro. Methods: Fungal inhibition zone surface areas of isolates from two fungal genera ( Aspergillus and Fusarium spp.) were compared in triplicates after UV‐C exposure at distances of 10, 15, and 20 mm with single or repeat doses (4 h apart) of 5, 10, 15, or 30 s duration after 24, 48, and 72 h of incubation. Inhibition zones were microscopically assessed, and regrowth checks were performed. Results: Fungal inhibition was achieved with the lowest exposures/doses of 5 s/7.5 mJ/cm 2 and 10 s/7 mJ/cm 2 at distances of 10 and 20 mm, respectively. At 10 mm, the fungal inhibition zone was statistically significantly enlarged by increasing exposure/dose from 5 s to 15 s/22.5 mJ/cm 2 for all isolates. Only Aspergillus flavus showed a further significant zone enlargement after a 30 s/45 mJ/cm 2 exposure/dose. Fungal inhibition zone sizes did not differ significantly between isolates after 15 s exposure regardless of distance, but an increased distance led to a subjective increase in fungal regrowth. While inhibition zones decreased over time, no central growth was noted despite the lack of complete fungal eradication. Conclusions: For Aspergillus and Fusarium spp., an exposure/dose of 15 s at a 10 mm distance/22.5 mJ/cm 2 may optimally align antifungal efficacy with previously reported corneal safety data. Further preclinical and safety studies are required to ensure that this effect translates into clinical practice.
- 5 March 2025
- Published by Wiley in Veterinary Ophthalmology
- Vol. 29 (1)
Open AccessUltraviolet C ( UV ‐C) Light Therapy for Equine Ulcerative Keratomycosis—An In Vitro Study
Objectives: To assess if an affordable, commercially available 275 nm ultraviolet C (UV‐C) device can inhibit fungal pathogens associated with equine keratomycosis and to establish the optimal exposure time/dose required in vitro. Methods: Fungal inhibition zone surface areas of isolates from two fungal genera ( Aspergillus and Fusarium spp.) were compared in triplicates after UV‐C exposure at distances of 10, 15, and 20 mm with single or repeat doses (4 h apart) of 5, 10, 15, or 30 s duration after 24, 48, and 72 h of incubation. Inhibition zones were microscopically assessed, and regrowth checks were performed. Results: Fungal inhibition was achieved with the lowest exposures/doses of 5 s/7.5 mJ/cm 2 and 10 s/7 mJ/cm 2 at distances of 10 and 20 mm, respectively. At 10 mm, the fungal inhibition zone was statistically significantly enlarged by increasing exposure/dose from 5 s to 15 s/22.5 mJ/cm 2 for all isolates. Only Aspergillus flavus showed a further significant zone enlargement after a 30 s/45 mJ/cm 2 exposure/dose. Fungal inhibition zone sizes did not differ significantly between isolates after 15 s exposure regardless of distance, but an increased distance led to a subjective increase in fungal regrowth. While inhibition zones decreased over time, no central growth was noted despite the lack of complete fungal eradication. Conclusions: For Aspergillus and Fusarium spp., an exposure/dose of 15 s at a 10 mm distance/22.5 mJ/cm 2 may optimally align antifungal efficacy with previously reported corneal safety data. Further preclinical and safety studies are required to ensure that this effect translates into clinical practice.
- 31 October 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (5) , 879-885
The novel use of a sub‐palpebral lavage line as an indwelling stent to manage unilateral nasolacrimal duct obstruction in a cat
Objective: To describe a novel surgical approach to conjunctivorhinostomy for feline nasolacrimal duct obstruction.Animal Studied: A client‐owned 4‐year‐old female spayed domestic shorthair cat presented with chronic unilateral nasolacrimal duct obstruction of the right eye.Methods: Following obstruction confirmation via complete ophthalmic examination and dacryocystorhinography, conjunctivorhinostomy was performed under general anesthesia, and an indwelling sub‐palpebral lavage (SPL) line was placed to facilitate the formation of a new pathway for tear drainage. Specifically, the SPL footplate was sutured to the ventral conjunctival fornix with 5‐0 nylon and 6‐0 vicryl while the tubing was passed through the new pathway and the distal end of the tubing trimmed and tucked into a perinasal subcutaneous pocket. Two skin sutures closed the perinasal pocket and were removed 2 weeks postoperatively.Results: No immediate postoperative complications occurred. At 6 weeks and 6 months postoperatively, the distal SPL tubing was dislodged and visible out of the right nostril. This was uneventfully trimmed shorter, and no further complications occurred. The SPL component was easily removed 11 months postoperatively without complication. The patient's clinical signs dramatically improved; she was comfortable over 2 years after surgery.Conclusion: To the authors' knowledge, this is the first report of using an SPL as an indwelling catheter for nasolacrimal duct surgery via conjunctivorhinostomy in a cat. This technique eliminated external stent sites for the patient, which was associated with a short use of an e‐collar, and utilized materials readily available in a specialty hospital.
- 31 October 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (5) , 879-885
The novel use of a sub‐palpebral lavage line as an indwelling stent to manage unilateral nasolacrimal duct obstruction in a cat
Objective: To describe a novel surgical approach to conjunctivorhinostomy for feline nasolacrimal duct obstruction.Animal Studied: A client‐owned 4‐year‐old female spayed domestic shorthair cat presented with chronic unilateral nasolacrimal duct obstruction of the right eye.Methods: Following obstruction confirmation via complete ophthalmic examination and dacryocystorhinography, conjunctivorhinostomy was performed under general anesthesia, and an indwelling sub‐palpebral lavage (SPL) line was placed to facilitate the formation of a new pathway for tear drainage. Specifically, the SPL footplate was sutured to the ventral conjunctival fornix with 5‐0 nylon and 6‐0 vicryl while the tubing was passed through the new pathway and the distal end of the tubing trimmed and tucked into a perinasal subcutaneous pocket. Two skin sutures closed the perinasal pocket and were removed 2 weeks postoperatively.Results: No immediate postoperative complications occurred. At 6 weeks and 6 months postoperatively, the distal SPL tubing was dislodged and visible out of the right nostril. This was uneventfully trimmed shorter, and no further complications occurred. The SPL component was easily removed 11 months postoperatively without complication. The patient's clinical signs dramatically improved; she was comfortable over 2 years after surgery.Conclusion: To the authors' knowledge, this is the first report of using an SPL as an indwelling catheter for nasolacrimal duct surgery via conjunctivorhinostomy in a cat. This technique eliminated external stent sites for the patient, which was associated with a short use of an e‐collar, and utilized materials readily available in a specialty hospital.
- Open Access
- 8 August 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (4) , 699-713
Novel treatment of infectious keratitis in canine corneas using ultraviolet C (UV‐C) light
Objective: To investigate the therapeutic effect of 275 nm wavelength ultraviolet C (UV‐C) light for treatment of bacterial keratitis in canine corneas using an affordable, broadly available modified handheld device.Methods: UV‐C therapy (UVCT) was evaluated in two experiments: in vitro using triplicates of three bacterial genera (Staphylococcus, Streptococcus, Pseudomonas spp., and a mix of all species) where the UVCT was performed at a distance of 10, 15, and 20 mm with 1 or 2 doses (4 h apart) for 5, 15, or 30 s; ex vivo model where healthy canine corneal buttons were inoculated superficially and deep (330 μm) with the same bacterial isolates and treated at a 10 mm distance for 15 s with one dose of 22.5 mJ/cm2. Fluorescent marker (STYO9‐PI) was used to label (green = live bacteria, red = dead bacteria), and confocal microscopy was used to image the bacteria.Results: In vitro results showed all plates treated with UVCT had 100% bactericidal effect for all isolates with single dose of 15 s at 10 mm distance or two doses, 4 h apart at 15 mm and was ineffective with single dose at 15–20 mm. The ex vivo results confirmed a significant decrease in bacterial load for all isolates on samples inoculated superficially but were inconclusive for intrastromal ones.Conclusions: UVCT confirmed the therapeutic potential for all tested isolates, for both in vitro and ex vivo experiments using a single exposure of 15 s. While safety studies are underway, clinical trials are warranted.
- 8 August 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (4) , 699-713
Open AccessNovel treatment of infectious keratitis in canine corneas using ultraviolet C (UV‐C) light
Objective: To investigate the therapeutic effect of 275 nm wavelength ultraviolet C (UV‐C) light for treatment of bacterial keratitis in canine corneas using an affordable, broadly available modified handheld device.Methods: UV‐C therapy (UVCT) was evaluated in two experiments: in vitro using triplicates of three bacterial genera (Staphylococcus, Streptococcus, Pseudomonas spp., and a mix of all species) where the UVCT was performed at a distance of 10, 15, and 20 mm with 1 or 2 doses (4 h apart) for 5, 15, or 30 s; ex vivo model where healthy canine corneal buttons were inoculated superficially and deep (330 μm) with the same bacterial isolates and treated at a 10 mm distance for 15 s with one dose of 22.5 mJ/cm2. Fluorescent marker (STYO9‐PI) was used to label (green = live bacteria, red = dead bacteria), and confocal microscopy was used to image the bacteria.Results: In vitro results showed all plates treated with UVCT had 100% bactericidal effect for all isolates with single dose of 15 s at 10 mm distance or two doses, 4 h apart at 15 mm and was ineffective with single dose at 15–20 mm. The ex vivo results confirmed a significant decrease in bacterial load for all isolates on samples inoculated superficially but were inconclusive for intrastromal ones.Conclusions: UVCT confirmed the therapeutic potential for all tested isolates, for both in vitro and ex vivo experiments using a single exposure of 15 s. While safety studies are underway, clinical trials are warranted.
- 16 June 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (1) , 73-80
Ocular diagnostics, ophthalmic findings, and conjunctival microbiome in the Chilean flamingo (Phoenicopterus chilensis)
Objective: To establish normative data for selected ocular diagnostic tests and commensal conjunctival microflora and describe the incidence of ocular pathology in Chilean flamingos.Animals Studied: A total of 41 Chilean flamingos were examined at the Blank Park Zoo in Des Moines, Iowa.Procedures: In 20 flamingos, blink rate was assessed undisturbed in their exhibit, then gentle manual restraint was used to assess palpebral fissure length (PFL), aqueous tear production (phenol red thread test [PRTT] in one eye, endodontic absorbent paper point tear test [EAPPTT] in the other), intraocular pressure (IOP; rebound tonometry), and fluorescein staining. Twenty‐one other flamingos were brought to a darkened area for neuro‐ophthalmic examination, slit lamp biomicroscopy, and indirect ophthalmoscopy. Swabs from seven flamingos were used for ocular microbiome evaluation.Results: Results are presented as mean ± standard deviation (range). Flamingos comprised 23 females/18 males, aged 11 ± 9.1 (0.7–40) years. Test results: blink rate, 3.7 ± 2 (1–9) blinks/min; PFL, 11.2 ± 1.2 (9–14) mm; IOP, 14 ± 3.2 (10–22) mmHg; EAPPT, 10.2 ± 2.8 (9–14) mm/min; PRTT, 6.8 ± 2.5 (3–13) mm/15 s. Dazzle reflex was positive in four birds examined. Pathologies included cataracts (n = 7 birds), corneal fibrosis (n = 3), endothelial pigment (n = 2), uveal cysts (n = 1), lens luxation (n = 1), and uveitis (n = 1). Ocular microbiome showed high diversity of taxa.Conclusions: Baseline ocular parameters and incidence of ophthalmic pathology assist veterinarians with disease screening for Chilean flamingos, while the ocular microbiome showed high diversity.
- 16 June 2024
- Published by Wiley in Veterinary Ophthalmology
- Vol. 28 (1) , 73-80
Ocular diagnostics, ophthalmic findings, and conjunctival microbiome in the Chilean flamingo (Phoenicopterus chilensis)
Objective: To establish normative data for selected ocular diagnostic tests and commensal conjunctival microflora and describe the incidence of ocular pathology in Chilean flamingos.Animals Studied: A total of 41 Chilean flamingos were examined at the Blank Park Zoo in Des Moines, Iowa.Procedures: In 20 flamingos, blink rate was assessed undisturbed in their exhibit, then gentle manual restraint was used to assess palpebral fissure length (PFL), aqueous tear production (phenol red thread test [PRTT] in one eye, endodontic absorbent paper point tear test [EAPPTT] in the other), intraocular pressure (IOP; rebound tonometry), and fluorescein staining. Twenty‐one other flamingos were brought to a darkened area for neuro‐ophthalmic examination, slit lamp biomicroscopy, and indirect ophthalmoscopy. Swabs from seven flamingos were used for ocular microbiome evaluation.Results: Results are presented as mean ± standard deviation (range). Flamingos comprised 23 females/18 males, aged 11 ± 9.1 (0.7–40) years. Test results: blink rate, 3.7 ± 2 (1–9) blinks/min; PFL, 11.2 ± 1.2 (9–14) mm; IOP, 14 ± 3.2 (10–22) mmHg; EAPPT, 10.2 ± 2.8 (9–14) mm/min; PRTT, 6.8 ± 2.5 (3–13) mm/15 s. Dazzle reflex was positive in four birds examined. Pathologies included cataracts (n = 7 birds), corneal fibrosis (n = 3), endothelial pigment (n = 2), uveal cysts (n = 1), lens luxation (n = 1), and uveitis (n = 1). Ocular microbiome showed high diversity of taxa.Conclusions: Baseline ocular parameters and incidence of ophthalmic pathology assist veterinarians with disease screening for Chilean flamingos, while the ocular microbiome showed high diversity.
- Open Access
- 2 September 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (6) , 560-564
Retrospective evaluation of the incidence of gastrointestinal bleeding in dogs receiving ophthalmic nonsteroidal anti‐inflammatory drugs
ObjectivesTo report the incidence of gastrointestinal (GI) bleeding and associated risk factors in a population of dogs receiving ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs).Animal StudiedMedical records of dogs prescribed ophthalmic NSAIDs (cases), dogs receiving systemic NSAIDs alone and dogs receiving systemic prednisone alone (controls).ProceduresData were collected retrospectively from the medical records of 204 dogs prescribed ophthalmic NSAIDs (diclofenac, ketorolac, or flurbiprofen), which were subdivided based on if they received any concurrent systemic NSAIDs or glucocorticoids, 136 dogs receiving a systemic NSAID (carprofen or meloxicam) alone, and 151 dogs receiving a systemic glucocorticoid (prednisone) alone at a referral hospital from 2015 to 2019.ResultsGastrointestinal bleeds developed in 8/79 (10.1%) of topical NSAID-only cases, 10/136 (7.4%) of systemic NSAID controls, and 14/151 (9.3%) of systemic glucocorticoid controls, with no significant difference between the three groups (p = .6103). There were no significant differences in GI bleed rates between cases treated with ketorolac, diclofenac, or flurbiprofen (p = .160), although severe GI bleeding was only seen in ketorolac-treated dogs. Presence of a known concurrent risk factor for GI bleeding was significantly associated with the development of GI bleed in dogs on ophthalmic NSAIDs (p = .032).ConclusionsDogs treated with ophthalmic NSAIDs developed GI bleeding at a frequency comparable to dogs receiving systemic NSAIDs or systemic glucocorticoids alone, suggesting that dogs receiving ophthalmic NSAIDs may be at increased risk of GI bleeding.
- 2 September 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (6) , 560-564
Open AccessRetrospective evaluation of the incidence of gastrointestinal bleeding in dogs receiving ophthalmic nonsteroidal anti‐inflammatory drugs
ObjectivesTo report the incidence of gastrointestinal (GI) bleeding and associated risk factors in a population of dogs receiving ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs).Animal StudiedMedical records of dogs prescribed ophthalmic NSAIDs (cases), dogs receiving systemic NSAIDs alone and dogs receiving systemic prednisone alone (controls).ProceduresData were collected retrospectively from the medical records of 204 dogs prescribed ophthalmic NSAIDs (diclofenac, ketorolac, or flurbiprofen), which were subdivided based on if they received any concurrent systemic NSAIDs or glucocorticoids, 136 dogs receiving a systemic NSAID (carprofen or meloxicam) alone, and 151 dogs receiving a systemic glucocorticoid (prednisone) alone at a referral hospital from 2015 to 2019.ResultsGastrointestinal bleeds developed in 8/79 (10.1%) of topical NSAID-only cases, 10/136 (7.4%) of systemic NSAID controls, and 14/151 (9.3%) of systemic glucocorticoid controls, with no significant difference between the three groups (p = .6103). There were no significant differences in GI bleed rates between cases treated with ketorolac, diclofenac, or flurbiprofen (p = .160), although severe GI bleeding was only seen in ketorolac-treated dogs. Presence of a known concurrent risk factor for GI bleeding was significantly associated with the development of GI bleed in dogs on ophthalmic NSAIDs (p = .032).ConclusionsDogs treated with ophthalmic NSAIDs developed GI bleeding at a frequency comparable to dogs receiving systemic NSAIDs or systemic glucocorticoids alone, suggesting that dogs receiving ophthalmic NSAIDs may be at increased risk of GI bleeding.
- Open Access
- 23 June 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (4) , 331-338
Increased drug concentration and repeated eye drop administration as strategies to optimize topical drug delivery: A fluorophotometric study in healthy dogs
Objectives: Determine tear film kinetics with different fluorescein concentrations and repeated eye drop administration at various time intervals.Animals Studied: Six healthy Beagles.Procedures: Six experiments were conducted on separate days: single eye drop administration (control) or two separate eye drops administered at 30 s, 1, 2, 5, and 10 min intervals. For each experiment, one eye received 0.3% fluorescein solution while the other eye received 1% fluorescein solution, and tear fluid was collected with capillary tubes at 0, 1, 5, 10, 20, 30, 40, 50, 60, 90, 120, and 180 min. Fluorescein concentrations were measured using automated fluorophotometry.Results: Compared with 0.3% solution, eyes receiving 1% fluorescein solution had significantly higher tear film concentrations (p ≤ .046) and the area‐under‐the‐fluorescein‐time curve was twofold greater (p = .005). Compared with control: (i) Tear film concentrations were significantly higher for up to 20 min when repeating administration 30 s to 5 min after the first drop (p ≤ .006); (ii) The highest increase in area‐under‐the‐curve was obtained with 2 and 5 min intervals for 0.3% (+109%–130%) and 1% solutions (+153%–157%); (iii) The highest increase in median precorneal retention time (defined as tear film concentration < 5% from baseline values) was obtained with 5 min intervals for 0.3% (55 min vs. 15 min in control) and 2–5 min intervals for 1% solutions (50 min vs. 25 min in control).Conclusions: Drug delivery to the ocular surface can be enhanced by using more concentrated formulations and/or by repeating eye drop administration 2–5 min after the first dose.
- 23 June 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (4) , 331-338
Open AccessIncreased drug concentration and repeated eye drop administration as strategies to optimize topical drug delivery: A fluorophotometric study in healthy dogs
Objectives: Determine tear film kinetics with different fluorescein concentrations and repeated eye drop administration at various time intervals.Animals Studied: Six healthy Beagles.Procedures: Six experiments were conducted on separate days: single eye drop administration (control) or two separate eye drops administered at 30 s, 1, 2, 5, and 10 min intervals. For each experiment, one eye received 0.3% fluorescein solution while the other eye received 1% fluorescein solution, and tear fluid was collected with capillary tubes at 0, 1, 5, 10, 20, 30, 40, 50, 60, 90, 120, and 180 min. Fluorescein concentrations were measured using automated fluorophotometry.Results: Compared with 0.3% solution, eyes receiving 1% fluorescein solution had significantly higher tear film concentrations (p ≤ .046) and the area‐under‐the‐fluorescein‐time curve was twofold greater (p = .005). Compared with control: (i) Tear film concentrations were significantly higher for up to 20 min when repeating administration 30 s to 5 min after the first drop (p ≤ .006); (ii) The highest increase in area‐under‐the‐curve was obtained with 2 and 5 min intervals for 0.3% (+109%–130%) and 1% solutions (+153%–157%); (iii) The highest increase in median precorneal retention time (defined as tear film concentration < 5% from baseline values) was obtained with 5 min intervals for 0.3% (55 min vs. 15 min in control) and 2–5 min intervals for 1% solutions (50 min vs. 25 min in control).Conclusions: Drug delivery to the ocular surface can be enhanced by using more concentrated formulations and/or by repeating eye drop administration 2–5 min after the first dose.
- Open Access
- 7 February 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (S1) , 81-88
Precorneal retention time of ocular lubricants measured with fluorophotometry in healthy dogs
Objective: Determine the precorneal retention time of five different ocular lubricants commonly used in dogs.Animals Studied: Six healthy Beagle dogs (n = 12 eyes).Procedures: Five ocular lubricants were studied: Artificial Tears Solution® (1.4% polyvinyl alcohol), I‐Drop® Vet Plus (0.25% hyaluronate), Optixcare® Eye Lube Plus (0.25% hyaluronate), Systane® Ultra (0.4% polyethylene glycol 400 and 0.3% propylene glycol), and Artificial Tears Ointment® (mineral oil/white petrolatum). Each lubricant was mixed with 10% sodium fluorescein to achieve 1% fluorescein formulations. Following topical administration of 35 mg in each eye, tear fluid was collected with capillary tubes at selected times (0, 1, 5, 10, 20, 30, 40, 50, 60, 90, 120, 180 min) and fluorescein concentrations were measured with a computerized scanning ocular fluorophotometer.Results: Tear fluorescence was significantly greater with Artificial Tears Ointment® compared with other lubricant formulations from 1 to 20 min post‐administration. Median (range) precorneal retention times were significantly different among the 5 lubricants, ranging from 40 minutes (20–90 min) for Artificial Tears Ointment®, 35 min (20–90 min) for Systane® Ultra, 30 min (10–60 min) for I‐Drop® Vet Plus, 25 min (10–60 min) for Optixcare® Eye Lube Plus, and 10 min (10–20 min) for Artificial Tears Solution®. Precorneal retention time was significantly lower for Artificial Tears Solution® compared with the other 4 formulations.Conclusions: This study established normative data for the retention time of common lubricants on the ocular surface of dogs, which may be used to guide clinicians with their choice of lubricant and frequency of administration.
- 7 February 2023
- Published by Wiley in Veterinary Ophthalmology
- Vol. 26 (S1) , 81-88
Open AccessPrecorneal retention time of ocular lubricants measured with fluorophotometry in healthy dogs
Objective: Determine the precorneal retention time of five different ocular lubricants commonly used in dogs.Animals Studied: Six healthy Beagle dogs (n = 12 eyes).Procedures: Five ocular lubricants were studied: Artificial Tears Solution® (1.4% polyvinyl alcohol), I‐Drop® Vet Plus (0.25% hyaluronate), Optixcare® Eye Lube Plus (0.25% hyaluronate), Systane® Ultra (0.4% polyethylene glycol 400 and 0.3% propylene glycol), and Artificial Tears Ointment® (mineral oil/white petrolatum). Each lubricant was mixed with 10% sodium fluorescein to achieve 1% fluorescein formulations. Following topical administration of 35 mg in each eye, tear fluid was collected with capillary tubes at selected times (0, 1, 5, 10, 20, 30, 40, 50, 60, 90, 120, 180 min) and fluorescein concentrations were measured with a computerized scanning ocular fluorophotometer.Results: Tear fluorescence was significantly greater with Artificial Tears Ointment® compared with other lubricant formulations from 1 to 20 min post‐administration. Median (range) precorneal retention times were significantly different among the 5 lubricants, ranging from 40 minutes (20–90 min) for Artificial Tears Ointment®, 35 min (20–90 min) for Systane® Ultra, 30 min (10–60 min) for I‐Drop® Vet Plus, 25 min (10–60 min) for Optixcare® Eye Lube Plus, and 10 min (10–20 min) for Artificial Tears Solution®. Precorneal retention time was significantly lower for Artificial Tears Solution® compared with the other 4 formulations.Conclusions: This study established normative data for the retention time of common lubricants on the ocular surface of dogs, which may be used to guide clinicians with their choice of lubricant and frequency of administration.
- Open Access
- 24 November 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 1083294
Impact of multi-drug resistance on clinical outcomes of dogs with corneal ulcers infected with Staphylococcus pseudintermedius
Objective: Compare characteristics and clinical outcomes of dogs with infectious keratitis from Staphylococcus pseudintermedius considered to be multidrug-resistant (MDR) or not.Procedures: Staphylococcus pseudintermedius isolated as the primary pathogen from canine patients with ulcerative keratitis were considered MDR if resistant to at least one agent in three or more classes of antibiotics. Medical records were reviewed for history, patients' characteristics, clinical appearance, therapeutic interventions, and clinical outcomes.Results: Twenty-eight dogs (28 eyes) were included. Compared to non-MDR cases, MDR diagnosis was significantly more common in dogs with recent (≤30 days) anesthesia (7/15 vs. 1/13, P = 0.038) and more common in non-brachycephalic dogs (8/15 vs. 2/13, P = 0.055). Clinical appearance (ulcer size/depth, anterior chamber reaction, etc.) did not differ significantly between groups (P ≥ 0.055). Median (range) time to re-epithelialization was longer in MDR vs. non-MDR eyes [29 (10–47) vs. 22 (7–42) days] but the difference was not significant (P = 0.301). Follow-up time was significantly longer in dogs with MDR keratitis [47 (29–590) vs. 29 (13–148) days, P = 0.009]. No other significant differences were noted between MDR and non-MDR eyes in regard to time for ulcer stabilization [4 (1–17) days vs. 4 (1–12), P = 0.699], number of eyes requiring surgical stabilization (7/15 vs. 7/13, P = 0.246) or enucleation (1/15 vs. 2/13, P = 1.000), success in maintaining globe (14/15 vs. 11/13, P = 0.583) or success in maintaining vision (12/15 vs. 10/13, P = 1.000).Conclusions: MDR infections may prolong corneal healing time but did not appear to affect overall clinical outcomes in dogs with bacterial keratitis. Further research is warranted in a larger canine population and other bacterial species.
- 24 November 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 1083294
Open AccessImpact of multi-drug resistance on clinical outcomes of dogs with corneal ulcers infected with Staphylococcus pseudintermedius
Objective: Compare characteristics and clinical outcomes of dogs with infectious keratitis from Staphylococcus pseudintermedius considered to be multidrug-resistant (MDR) or not.Procedures: Staphylococcus pseudintermedius isolated as the primary pathogen from canine patients with ulcerative keratitis were considered MDR if resistant to at least one agent in three or more classes of antibiotics. Medical records were reviewed for history, patients' characteristics, clinical appearance, therapeutic interventions, and clinical outcomes.Results: Twenty-eight dogs (28 eyes) were included. Compared to non-MDR cases, MDR diagnosis was significantly more common in dogs with recent (≤30 days) anesthesia (7/15 vs. 1/13, P = 0.038) and more common in non-brachycephalic dogs (8/15 vs. 2/13, P = 0.055). Clinical appearance (ulcer size/depth, anterior chamber reaction, etc.) did not differ significantly between groups (P ≥ 0.055). Median (range) time to re-epithelialization was longer in MDR vs. non-MDR eyes [29 (10–47) vs. 22 (7–42) days] but the difference was not significant (P = 0.301). Follow-up time was significantly longer in dogs with MDR keratitis [47 (29–590) vs. 29 (13–148) days, P = 0.009]. No other significant differences were noted between MDR and non-MDR eyes in regard to time for ulcer stabilization [4 (1–17) days vs. 4 (1–12), P = 0.699], number of eyes requiring surgical stabilization (7/15 vs. 7/13, P = 0.246) or enucleation (1/15 vs. 2/13, P = 1.000), success in maintaining globe (14/15 vs. 11/13, P = 0.583) or success in maintaining vision (12/15 vs. 10/13, P = 1.000).Conclusions: MDR infections may prolong corneal healing time but did not appear to affect overall clinical outcomes in dogs with bacterial keratitis. Further research is warranted in a larger canine population and other bacterial species.